Metallothioneins (MT) take part in the homeostasis of the metals which are necessary for the proper metabolism and they also take part in the detoxication of toxic metals from the tissues. They also protect the tissue from the effects of reactive oxygen species, radiation, electrophilic pharmacologic agents used in the cancer therapy and from mutagens. Manganese (Mn) – essential microelement – seems to be very important during development. Mn takes a part as cofactor of the enzymes regulating the metabolism. This microelement also participates in the reductionoxidation
reactions. An example of such reaction is the superoxide dismutase (MnSOD) activity with manganese as enzyme component. It is thought that manganese and manganese superoxide dismutase play an important role in the differentiating cells. The aim of this work was to determine the level of metallothionein and manganese in the brain neoplastic tissues, astrocytoma G-2 and malignant gliomas (astrocytoma G-4). The experimental materials were primary glial the brain neoplastic tissues resected during neurosurgical procedures. The level of the metallothionein was determined by the cadmium-hemoglobin affinity assay using the cadmium isotope (109Cd), and the concentration of manganese was determined by atomic absorption spectrometry. The concentration of metallothionein and manganese was found to be higher in the astrocytoma G-4 (glioblastoma multiforme) patients. Negative correlation between the concentration of metallothionein and manganese ions was found in astrocytoma G-2 cells
REFERENCES(35)
1.
Bremner I: Interaction between metallothionein and trace elements. Prog Food Nutr Sci 1987, 11, 1-37.
Floriańczyk B, Marciniak B, Baranowski W, Oleszczuk J, Stryjecka- Zimmer M: The concentration of metalothionein in placenta membrane in human Proceed. X Symposium of Gestosis and Hypertension in Pregnancy Division of Polish Gynecological Society, Lublin, 1998, 138-141.
Floriańczyk B, Osuchowski J, Kaczmarczyk R, Trojanowski T: Influence of metallothioneins on zinc and copper distribution in brain tumours. Folia Neuropathol 2003, 41, 11-14.
Takeda A. Tamano H, Hoshino A: Elevation of hepatic levels of metallothionein during experimental carcinogenesis. Biol Trace Elem Res 1994, 41, 157 164.
Palmiter RD: Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor MTF-1. Proc Natl Acad Sci USA 1994, 91, 1219-1223.
Choudhuri S, McKim JM, Klaassen CD: Differential expression of the metallothionein gene in liver and brain of mice and rats. Toxicol Appl Pharmacol 1993, 119, 1-10.
The Journal of Pre-Clinical and Clinical Research welcomes article submissions and does not charge a publication fee. Submit your article today and gain worldwide visibility for your article.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.